1,895 Shares in Cardinal Health, Inc. $CAH Acquired by Ibex Wealth Advisors

Ibex Wealth Advisors acquired a new position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 1,895 shares of the company’s stock, valued at approximately $422,000.

Other large investors also recently added to or reduced their stakes in the company. Pinnacle Associates Ltd. lifted its holdings in shares of Cardinal Health by 2.9% in the third quarter. Pinnacle Associates Ltd. now owns 1,404 shares of the company’s stock valued at $312,000 after purchasing an additional 39 shares in the last quarter. Parallel Advisors LLC boosted its position in shares of Cardinal Health by 1.4% in the third quarter. Parallel Advisors LLC now owns 3,004 shares of the company’s stock worth $668,000 after buying an additional 41 shares during the period. LWM Advisors Inc. boosted its position in shares of Cardinal Health by 4.4% in the second quarter. LWM Advisors Inc. now owns 1,028 shares of the company’s stock worth $244,000 after buying an additional 43 shares during the period. Parkside Financial Bank & Trust boosted its position in shares of Cardinal Health by 2.5% in the second quarter. Parkside Financial Bank & Trust now owns 1,793 shares of the company’s stock worth $426,000 after buying an additional 43 shares during the period. Finally, Raleigh Capital Management Inc. grew its holdings in shares of Cardinal Health by 2.9% during the third quarter. Raleigh Capital Management Inc. now owns 1,541 shares of the company’s stock valued at $343,000 after buying an additional 43 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts recently weighed in on CAH shares. Leerink Partners set a $292.00 price target on Cardinal Health in a research report on Tuesday, August 11th. TD Cowen increased their price objective on Cardinal Health from $280.00 to $304.00 and gave the stock a “buy” rating in a research note on Monday, November 9th. Royal Bank Of Canada raised their price objective on Cardinal Health from $276.00 to $295.00 and gave the stock an “outperform” rating in a research report on Friday, November 6th. Morgan Stanley lifted their target price on Cardinal Health from $265.00 to $286.00 and gave the company an “overweight” rating in a research note on Friday, October 30th. Finally, Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, October 25th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $279.44.

View Our Latest Stock Report on CAH

Insider Activity

In other Cardinal Health news, CAO Mary C. Scherer sold 2,302 shares of the business’s stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $237.39, for a total value of $546,471.78. Following the transaction, the chief accounting officer owned 2,811 shares in the company, valued at $667,303.29. The trade was a 45.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Jason Hollar sold 44,529 shares of the business’s stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $236.18, for a total value of $10,516,859.22. Following the completion of the transaction, the chief executive officer owned 190,603 shares in the company, valued at $45,016,616.54. This trade represents a 18.94% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 210,271 shares of company stock valued at $49,626,657. 0.12% of the stock is currently owned by company insiders.

Cardinal Health Stock Up 0.2%

Shares of NYSE:CAH opened at $281.55 on Monday. The firm has a fifty day moving average of $244.15 and a two-hundred day moving average of $225.24. The firm has a market capitalization of $65.08 billion, a P/E ratio of 36.42, a price-to-earnings-growth ratio of 2.15 and a beta of 0.53. Cardinal Health, Inc. has a 12-month low of $180.45 and a 12-month high of $286.29.

Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The company reported $3.26 EPS for the quarter, beating the consensus estimate of $2.94 by $0.32. Cardinal Health had a net margin of 0.71% and a negative return on equity of 102.72%. The business had revenue of $67.51 billion for the quarter, compared to analysts’ expectations of $66.67 billion. During the same period in the previous year, the company posted $2.55 EPS. Cardinal Health’s revenue was up 5.5% on a year-over-year basis. Equities research analysts expect that Cardinal Health, Inc. will post 12.97 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 15th. Investors of record on Monday, January 4th will be given a dividend of $0.5158 per share. The ex-dividend date of this dividend is Monday, January 4th. This represents a $2.06 dividend on an annualized basis and a yield of 0.7%. Cardinal Health’s dividend payout ratio (DPR) is presently 26.65%.

About Cardinal Health

(Free Report)

Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.

Read More

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.